Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2017 June;59(2) > Panminerva Medica 2017 June;59(2):173-87

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,698


eTOC

 

REVIEW  CONSERVATIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE: HOW TO AVOID OR DEFER DIALYSIS


Panminerva Medica 2017 June;59(2):173-87

DOI: 10.23736/S0031-0808.16.03282-1

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Microbiota and prebiotics modulation of uremic toxin generation

Laetitia KOPPE, Denis FOUQUE

Department of Nephrology, Centre Hospitalier Lyon Sud, Cardiovascular, Metabolism, Diabetology and Nutrition (CarMeN) Lab, European Center for Nutrition and Health (CENS), University of Lyon, Lyon, France


PDF  


Recent data have shown that the host-intestinal microbiota interaction is intrinsically linked with overall health. Chronic kidney disease (CKD) could influence intestinal microbiota and gut dysbiosis is also considered as a cause of progression of kidney disease. An increasing body of evidence indicates that dysbiosis is a key contributor of uremic retention solutes (URS) accumulating in patients with CKD. The discovery of the kidney-gut axis has created new therapeutic opportunities for nutritional intervention in order to prevent adverse outcomes. One of these strategies is prebiotics, which refers to nondigestible food ingredients or substances that beneficial affect growth and/or activity of limited health-promoting bacteria in the gastrointestinal tract. The influence of prebiotics on the production and concentration of URS have been investigated in various animal and human CKD studies. However, to date, there is still paucity of high-quality intervention trials. Randomized controlled trials and adequately powered intervention studies are needed before recommending prebiotics in clinical practice. This review will outline the interconnection between CKD progression, dysbiosis and URS production and will discuss mechanisms of action and efficacy of prebiotics as a new CKD management tool, with a particular emphasis on URS generation.


KEY WORDS: Microbiota - Probiotics - Uremia middle molecule toxins - Chronic kidney disease-mineral and bone disorder

top of page

Publication History

Issue published online: February 10, 2017
Article first published online: December 21, 2016

Cite this article as

Koppe L, Fouque D. Microbiota and prebiotics modulation of uremic toxin generation. Panminerva Med 2017;59:173-87.DOI: 10.23736/S0031-0808.16.03282-1

Corresponding author e-mail

denis.fouque@chu-lyon.fr